Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update
Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update 21.02.2023 / 07:00 CET/CEST MEDIA RELEASE KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptoms KINFAST is actively...
Chris Maggos Thierry Fumeaux Research Update Study Kinarus Therapeutics Holding Ag Key Swiss Federal Office Of Public Health Cohesion Bureau
Source: boersennews.de